NeoGenomics, Inc. Unrecognized Tax Benefits, Increase Resulting from Acquisition
NeoGenomics, Inc. (NEO) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $498.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2026-02-17
- NeoGenomics, Inc. unrecognized tax benefits, increase resulting from acquisition for fiscal 2025 was $498.00K.
- NeoGenomics, Inc. unrecognized tax benefits, increase resulting from acquisition for fiscal 2024 was $0.00.
- NeoGenomics, Inc. unrecognized tax benefits, increase resulting from acquisition for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- NeoGenomics, Inc. unrecognized tax benefits, increase resulting from acquisition for fiscal 2022 was $82.00K, a 1.20% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month |
|---|---|
| 2025-12-31 | $498.00K 10-K · filed 2026-02-17 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2022-12-31 | $82.00K 10-K · filed 2025-02-18 |
| 2021-12-31 | $83.00K 10-K · filed 2024-02-20 |
| 2020-12-31 | $1.02M 10-K · filed 2022-02-25 |
| 2019-12-31 | $27.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $632.00K 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |